The India veterinary diagnostic test kits market size is expected to grow from US$ 29.13 million in 2022 to US$ 62.03 million by 2030; it is estimated to register a CAGR of 9.91% from 2022 to 2030.

Market Insights and Analyst View:

Veterinary diagnostic test kits include tools and consumables used by veterinarians to diagnose and monitor animal health conditions. These kits are designed to detect the presence of specific markers such as antibodies, antigens, or DNA in animal blood, urine, feces, and other samples. Veterinary diagnostic test kits are available for a wide range of animal species, including dogs, cats, horses, cows, pigs, and birds. These kits are essential for diagnosing infectious diseases, genetic disorders, and other health conditions in animals. The India veterinary diagnostic test kits market report emphasizes the key factors driving the market and depicts the developments of prominent players.

Key factors driving the India veterinary diagnostic test kits market growth include the rising prevalence of zoonotic disease, an increase in the adoption of companion animals, and a shift toward POCT testing in animals. However, the lack of skilled professionals in veterinary research and the inadequacy of veterinary diagnostics infrastructure hinder market growth. Further, the increasing expenditure on animal well-being is expected to bring new India veterinary diagnostic test kits market trends in the coming years.

Growth Drivers and Restraints:

Pet adoption has been on the rise in India over the past few years, which has subsequently increased the demand for veterinary diagnostic testing kits. According to the Brand Equity Foundation, the number of pet owners in India surged from 20 million in 2015 to 30 million in 2023. Products and services for the healthcare and grooming of pets are in high demand as more people and families bring pets into their homes. As more and more people adopt pets, they become more invested in their pet's health and well-being. This has led to an upsurge in demand for regular veterinary check-ups and diagnostic testing among pet owners. Additionally, many rescue organizations and animal shelters require pets to undergo diagnostic testing before they are adopted to ensure that they are healthy and free from infectious diseases.

The availability of veterinary diagnostic testing kits has made it easier for veterinarians to diagnose and treat a variety of diseases, including infectious diseases that can be easily spread among animals. These tests allow veterinarians to quickly identify the cause of an animal's symptoms, which can help them provide prompt and effective treatment. This is particularly important in India, where infectious diseases are a major concern due to overcrowding and poor sanitation. Furthermore, the increasing demand for veterinary diagnostic testing kits has led to the development of new and improved testing methods.

Rapid diagnostic tests available in the market can provide results in just a few minutes, making it easier for veterinarians to diagnose diseases quickly and accurately. Furthermore, the development of new and improved testing methods has made it easier for pet doctors to diagnose diseases accurately, which has helped to control the spread of infectious diseases among companion animals. In February 2023, Thermo Fisher Scientific launched Applied Biosystems TaqPath PCR kits for diagnosing infectious diseases, including multidrug-resistant tuberculosis, hepatitis B virus, hepatitis C virus, M. tuberculosis complex, and others. The kits are compatible with animal and human samples, such as buccal swabs, blood, and card punches. The Central Drugs Standard Control Organization granted licensing rights to Thermo Fisher Scientific to manufacture the kits in association with Mylab Discovery Solutions in India. Thus, the growing trend of pet adoption in India has led to an increased demand for veterinary diagnostic testing kits, which provides a boost to the India veterinary diagnostic test kits market growth.

The lack of laboratory facilities, trained professionals, and diagnostic equipment has made it difficult for animal care providers to access timely and accurate diagnoses of animal diseases. This results in a low adoption rate of veterinary diagnostic test kits in India. Moreover, the high cost of diagnostic tests and the limited availability of diagnostic kits further restrict the growth of the market. Moreover, many animal care providers in India cannot afford expensive diagnostic tests. The limited availability of test kits further makes it difficult to diagnose a wide range of animal diseases. To address these concern, veterinary diagnostic test kit manufacturers in India need to focus on developing affordable, easy-to-use, and effective diagnostic test kits that can be used by animal care providers in areas with limited laboratory facilities. They also need to work closely with the government to improve the veterinary diagnostic infrastructure in the country, which would create opportunities for the growth of the market.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Get 10% FREE CUSTOMIZATION

India Veterinary Diagnostic Test Kits Market: Strategic Insights

Market Size Value in	US$ 29.13 million in 2022
Market Size Value by	US$ 62.03 million by 2030
Growth rate	CAGR of 8.4% from 2022 to 2030
Forecast Period	2022-2030
Base Year	2022

Mrinal

Have a question?

Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

 Speak to Analyst

Report Segmentation and Scope:

The India veterinary diagnostic test kits market analysis has been carried out by considering the following segments: product, animal type, application, testing type, and end user. Based on product, the market is differentiated into ELISA test kits, antibodies test kits, and polymerase chain reaction (PCR) test kits. By animal type, the India veterinary diagnostic test kits market is segmented into companion animals and livestock animals. In terms of application, the market is differentiated into infectious diseases and non-infectious diseases. On the basis of testing type, the India veterinary diagnostic test kits market is classified into rapid diagnostic testing, point-of-care testing, and laboratory testing. Based on end user, the India veterinary diagnostic test kits market is segmented into veterinary hospitals and clinics, animal diagnostic laboratories, and veterinary research institutes and universities.

Segmental Analysis:

Based on product, the ELISA test kit segment held the largest India veterinary diagnostic test kits market share in 2022. The PCR test kit segment is anticipated to register the highest CAGR during 2022–2030.

Based on Animal Type, the companion animals segment held a larger market share in 2022. The livestock animal segment is anticipated to register a higher CAGR from 2022 to 2030. By application, the infectious diseases segment held a larger India veterinary diagnostic test kits market share. The noninfectious diseases segment is anticipated to register a higher CAGR during 2022–2030.

Based on testing type, the laboratory testing segment held a larger share of the India veterinary diagnostic test kits market in 2022. The rapid testing (POC testing) segment is anticipated to register a higher CAGR during 2022–2030. In terms of end user, the veterinary hospitals and clinics segment is anticipated to account for a significant market share during 2022–2030.

India Veterinary Diagnostic Test Kits Market, by Product – 2022 and 2030

Access Data

Industry Developments and Future Opportunities:

The India veterinary diagnostic test kits market forecast can help stakeholders in this marketplace plan their growth strategies. A few initiatives taken by key players operating in the market are listed below:

In February 2023, Thermo Fisher Scientific launched Applied Biosystems TaqPath PCR kits for diagnosing the diagnosis of infectious diseases, including  such as multi-drug resistant tuberculosis, Hhepatitis B virus, hepatitis C virus, M. tuberculosis complex, and human immunodeficiency virus (HIV) infection. The kits are also used for genetic analysis of HLA B27. The kits are compatible with human and animal samples, such as buccal swabs, blood, and card punches. The Central Drugs Standard Control Organisation granted licensing rights to the company, and it will manufacture the kits in association with Mylab Discovery Solutions.

In December 2021, A'alda Vet India and Fujifilm India partnered to improve pet healthcare facilities. As part of the collaboration, Fujifilm India planned to offer DCC (Dogs, Cats & Companions) Animal Hospital willwith  receive cutting-edge medical and screening equipment from Fujifilm India. This is an initiative was taken by A'alda Vet to raise the bar for veterinary treatment in India. With more and more individuals adopting and caring for pets, India has one of the fastest-growing pet care markets in the world. Therefore, it is more crucial than ever for people to have improved access to local pet care facilities that meet international standards.

Competitive Landscape and Key Companies:

Zoetis, Inc.; Secure Diagnostics; Thermo Fisher Scientific; Inbios India; Ubio Bitechnology Systems; Gold Standerd Diagnostics; VMRD Inc.; Fujifilm, Randox Laboratories Ltd; and Idexx Laboratories are among the prominent players profiled in the India veterinary diagnostic test kits market report. These companies focus on new technologies, advancements in existing products, and geographic expansions to meet the burgeoning consumer demand and expand their product range in specialty portfolios.